{
    "symbol": "ADCT",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-09 11:07:11",
    "content": " So, one thing I would say is with ZYNLONTA, this launch is in a pretty challenging environment because during this COVID period where institutions were relatively shut down awareness of the product, particularly unaided awareness in the community is still relatively low, and while that to challenge I think it's equally provides a big opportunity because as Jennifer mentioned, now that we have the J-code established which was a key barrier for prescribing and access is really - we really saw it improve in Q2."
}